EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women

María Liz Bobadilla iD, Verónica Villagra iD, Héctor Castro, Marta von Horoch, Soraya Araya, Gerardo Deluca, Vanessa Salete de Paula

Pathogens · 2024

DOI: 10.3390/pathogens13030209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von María Liz Bobadilla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology, Central Laboratory of Public Health, Minister of Public Health and Social Welfare, Asunción 1429, Paraguay. Hauptthemen laut MEDLINE: Papillomavirus Infections, Sexual Behavior, Papillomavirus Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council of Science and Technology (CONACYT), Research, Education, and Biotechnologies Applied to Health (IEBAS) Project MERCOSUR Structural Convergence Fund (FOCEM), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES—Finance Code 001.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is a global health concern and ranks fourth among the most prevalent cancers in women worldwide. Human papillomavirus (HPV) infection is a known precursor of cervical cancer and preventive measures include prophylactic vaccines. This study focused on sexually active Paraguayan women aged 18–25 years, exploring the intersection of HPV vaccination and sexual behavior. Among 254 participants, 40.9% received the Gardasil-4 vaccine, with no significant differences in sexual behavior between the vaccinated and unvaccinated sexually active groups. However, a notable decrease in the prevalence of HPV among the vaccinated women highlights the efficacy of this vaccine in reducing infections. The prevalence of any HPV type was 37.5% in vaccinated participants compared to 56.7% in unvaccinated participants (p = 0.0026). High-risk HPV types showed a significant difference, with a prevalence of 26.0% in vaccinated women compared with 52.7% in unvaccinated women (p < 0.001). Although a potential decline in genital warts was observed among the vaccinated individuals, statistical significance (p = 0.0564) was not reached. Despite the challenges in achieving high vaccination coverage, the observed reduction in HPV prevalence underscores the importance of ongoing monitoring, healthcare professional recommendations, and comprehensive risk management. These findings contribute to dispelling concerns about HPV vaccination influencing sexual behavior, advocating further large-scale research to explore the impact of vaccines on various HPV types and potential cross-protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsSexual BehaviorPapillomavirus VaccinesHumansFemaleYoung AdultAdultAdolescentParaguayPrevalenceVaccinationHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Uterine Cervical NeoplasmsRisk-TakingPapillomaviridaeHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HPV vaccinationParaguaycervical cancerhuman papillomavirussexual behaviorvaccine impact

Substanzen

Papillomavirus VaccinesHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Autor:innen und Institutionen

  • Laboratory of Immunology, Central Laboratory of Public Health, Minister of Public Health and Social Welfare, Asunción 1429, Paraguay.
  • Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
  • Expanded Immunization Program, Minister of Public Health and Social Welfare, Asunción 1429, Paraguay.
  • Molecular Applications Laboratory, Faculty of Medicine, Northeast National University, Corrientes 1240, Argentina.

ORCID-Profile: María Liz Bobadilla, Verónica Villagra

Förderung

  • National Council of Science and Technology (CONACYT)
  • Research, Education, and Biotechnologies Applied to Health (IEBAS) Project MERCOSUR Structural Convergence Fund (FOCEM)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES—Finance Code 001
  • Improvement of Higher Education Personnel (Coordenação de Aper-feiçoamento de Pessoal de Nível Superior—CAPES)
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
  • Oswaldo Cruz Institute
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

Bobadilla, M. L., Villagra, V., Castro, H., von Horoch, M., Araya, S., Deluca, G., & de Paula, V. S. (2024). Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women. Pathogens. https://doi.org/10.3390/pathogens13030209

Vancouver

Bobadilla ML, Villagra V, Castro H, von Horoch M, Araya S, Deluca G, et al. Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women. Pathogens. 2024. doi:10.3390/pathogens13030209

BibTeX
@article{Bobadilla2024,
  author = {Bobadilla, María Liz and Villagra, Verónica and Castro, Héctor and von Horoch, Marta and Araya, Soraya and Deluca, Gerardo and de Paula, Vanessa Salete},
  title = {Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13030209}
}
Kostenlos starten →